Globeflex Capital’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4M Hold
119,252
0.43% 73
2026
Q1
$2.07M Buy
119,252
+39,457
+49% +$747K 0.31% 89
2025
Q4
$1.5M Buy
79,795
+8,792
+12% +$147K 0.23% 116
2025
Q3
$1.03M Sell
71,003
-14,205
-17% -$202K 0.16% 158
2025
Q2
$1.66M Hold
85,208
0.14% 134
2025
Q1
$1.51M Sell
85,208
-3,940
-4% -$84.9K 0.14% 134
2024
Q4
$1.91M Hold
89,148
0.16% 120
2024
Q3
$2.78M Buy
89,148
+83,705
+1,538% +$2.08M 0.27% 87
2024
Q2
$84.5K Buy
+5,443
New +$65.8K 0.01% 395
2020
Q3
Sell
-11,641
Closed -$412K 476
2020
Q2
$412K Buy
+11,641
New +$331K 0.1% 309
2015
Q2
Sell
-91
Closed -$1K 518
2015
Q1
$1K Sell
91
-40
-31% -$264 ﹤0.01% 426
2014
Q4
$1K Buy
+131
New +$878 ﹤0.01% 429

Other funds holding CDNA

Globeflex Capital's CDNA Position: Q2 2026 in Review

Globeflex Capital held its CareDx (CDNA) position steady in Q2 2026 at 119,252 shares worth $3.4M. The position accounts for 0.43% of the portfolio, ranked #73.

Globeflex Capital first reported a position in CDNA in Q4 2014 and has held it in 12 quarters since. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Globeflex Capital held 119,252 shares of CareDx worth $3.4M as of Q2 2026.
  • Globeflex Capital left its CareDx share count unchanged in Q2 2026.
  • CareDx made up 0.43% of Globeflex Capital's portfolio in Q2 2026, its #73 holding.
  • Globeflex Capital first reported a position in CareDx in Q4 2014 and has held it in 12 quarters since.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.